ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Ishita Drugs & Industries Ltd has issued physical letters to shareholders with weblinks for its FY 2025-26 Annual Report. The 33rd AGM is scheduled for September 30, 2026.
Ishita Drugs & Industries Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026, in compliance with SEBI regulations.
Ishita Drugs & Industries Ltd informed the BSE that the Annual Secretarial Compliance Report for FY26 is not applicable. The company is exempt under Regulation 15(2) of SEBI LODR as its paid-up equity capital is Rs. 2.99 Crore and net worth is Rs. 10.78 Crore, both below the mandatory reporting thresholds.